Turkey's Abdi Ibrahim in talks for minority-stake sale; AZ's Nexium as effective as surgery in reflux;

@FiercePharma: Forest shareholder demands CEO's resignation. Report | Follow @FiercePharma

> Abdi Ibrahim Ilac Sanayi & Ticaret, Turkey's biggest generic drugmaker, said it's in talks with foreign companies on the possible sale of a minority stake. Story

> AstraZeneca's Nexium is as effective as surgery for patients with gastroesophageal reflux disease, according to a five-year study published in the Journal of the American Medical Association. News

> Sanofi's Genzyme unit sued Allergan for patent royalties on sales of wrinkle filler Juvederm. Story

> Swiss pharmaceuticals company Roche (ROG.VX) said that new drug data show that its personalized health care approach is working for patients suffering from skin and lung cancer. Report

> Roche's Genentech unit sued Apotex for planning to sell a generic version of Valcyte, which treats a virus that afflicts transplant patients and people with AIDS, before its patent expires. Item

> Pfizer's Canadian chief said that country must adjust the rules around intellectual property or risk losing ground in the competitive world of biotech and pharmaceutical research. Article

Biotech News

@FierceBiotech: Biotechs pick up slack in antibiotics development. Article | Follow @FierceBiotech

@JohnCFierce: IMS expects US drug sales to grow from 0 to 3% per year to 2015, less than half the rate we've been seeing. Story | Follow @JohnCFierce

> Deal or no deal? Takeda scuttles report on imminent $13B pact for Nycomed. Report

> Roche cancer programs angle for a starring role at ASCO. Story

> CRO consolidation continues as inVentiv scoops up PharmaNet. Item

Drug Delivery News

> Consultant: Gene and cell therapy almost ready for prime time. Item

> 'Magnetofection' delivers DNA in experimental malaria vaccine. Article

> Microdosing project to help develop drugs for infants. Story

> More than one way to produce particles for inhaled drug delivery. Report

> Analyst: Fluzone Intradermal 'delivers the goods' in a patient-friendly system. Story

> 'Nanobot?" Maybe not, but cool, anyway. Item

Medical Device News

> Shire buys Advanced BioHealing for $750M. News

> Stryker to cut 142 jobs in Ireland. Report

> Medtronic's decision to end GPO contracts could aid rivals. Story

> Thulin tapped as 3M COO. Article

> Medtronic's CoreValve shows sustained quality of life improvements. Item

And Finally... A recent outbreak of mumps in Canada underscores the importance of getting the recommended two doses of measles-mumps-rubella (MMR) vaccine and not just one, according to a study. Report